Clinical Trial Update: Hydroxychloroquine in Primary Progressive Multiple Sclerosis [Phase 2]

View source ↗

Summary

Phase 2 trial update for hydroxychloroquine in primary progressive multiple sclerosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis Primary Progressive

Drugs mentioned

• Hydroxychloroquine (hydroxychloroquine)

Snippet

Sponsor: University of Calgary | Conditions: Multiple Sclerosis, Primary Progressive | Phase 2 | Status: COMPLETED